Caricamento...
Comparative effectiveness of infliximab and adalimumab in Crohn’s disease and ulcerative colitis
INTRODUCTION: The availability of monoclonal antibodies to tumor necrosis factor α (anti-TNF) has revolutionized management of Crohn’s disease (CD) and ulcerative colitis (UC). However, limited data exists regarding comparative effectiveness of these agents to inform clinical practice. METHODS: This...
Salvato in:
| Pubblicato in: | Inflamm Bowel Dis |
|---|---|
| Autori principali: | , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4792716/ https://ncbi.nlm.nih.gov/pubmed/26933751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0000000000000754 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|